Document is current
Any future updates will be listed below
-
Authors
Rosenthal, Elana S.
Lavoie, Marie-Claude C.
Traver, Edward
Gryczynski, Jan
Nordeck, Courtney
Carpenter, Joseph E.
Reece, Rebecca
Kuo, Irene
Catalanotti, Jillian S.
Steck, Alaina R.
Cooper, Garrett
Fujita, Ayako Wendy
Murphy, Sean M.
Mansfield, Megan E.
Ramadhani, Habib Omari
Silk, Rachel
Masur, Henry
Kattakuzhy, Sarah
-
Funding
Funding for this research was provided by:
National Institutes of Health (75N90023C00013)
- License Information
-
More Information
Article History
Received: 22 September 2025
Accepted: 6 February 2026
First Online: 4 March 2026
Declarations
:
: This study was initially approved by the WCG IRB on August 9, 2024. The study is registered in ClinicalTrials.gov NCT06513156 ( ). The consent form for the trial participants is included in Supplement 1.
: Willing to provide a participant model consent form on request.
: JG—no financial or competing interests to report; unrelated to the present study: part owner of COG Analytics, LLC; MPI on a NIDA-funded study that received in-kind medication from Indivior and Alkermes. All remaining authors declare that they have no competing interests.
